Alpha-lipoic acid enhances ischemic postconditioning-mediated improvement of myocardial infarction and apoptosis in diabetic rats with ischemia/reperfusion injury

Can J Physiol Pharmacol. 2023 Dec 1;101(12):682-691. doi: 10.1139/cjpp-2023-0044. Epub 2023 Jul 31.

Abstract

This work evaluated the combined effects of alpha-lipoic acid (ALA) and ischemic postconditioning (Post) on myocardial infarction and cell death in rats with chronic type-II diabetes following ischemia/reperfusion injury. The rats received a high-fat diet and were given one intraperitoneal injection of 35 mg/kg streptozotocin to induce chronic diabetes. They were then pretreated with ALA (100 mg/kg/day, orally) for 5 weeks before undergoing ischemia/reperfusion (I/R) insult. The hearts experienced 35 min regional ischemia through ligating the left anterior descending coronary artery, followed by 60 min reperfusion. The Post protocol involved 6 cycles of a 10/10 s algorithm, applied during the early stage of reperfusion. The use of Post alone did not significantly alter lactate dehydrogenase and infarct size levels, while ALA showed positive effects. Similar findings were observed for apoptotic changes with single treatments. However, the concurrent administration of ALA and Post significantly reduced the protein expressions of Bax, Bax/Bcl2, and cleaved caspase-3 while increasing Bcl2 expression. Additionally, the histopathological findings of the combined therapy were superior to those of single treatments. The concomitant use of ALA and Post effectively inhibited apoptosis, leading to cardiac recovery after I/R injury in diabetic conditions. This strategy could improve outcomes for preserving diabetic hearts following I/R insults.

Keywords: Post conditioning; alpha-lipoic acid; cardio-protection; diabetes; ischemia–reperfusion.

MeSH terms

  • Animals
  • Apoptosis
  • Diabetes Mellitus, Experimental* / metabolism
  • Ischemic Postconditioning* / methods
  • Myocardial Infarction* / metabolism
  • Myocardial Reperfusion Injury* / pathology
  • Myocardium / metabolism
  • Rats
  • Thioctic Acid* / pharmacology
  • Thioctic Acid* / therapeutic use
  • bcl-2-Associated X Protein / metabolism

Substances

  • Thioctic Acid
  • bcl-2-Associated X Protein